| |
| |
|
| Insider
Information: |
Ford Alfred J Jr |
| Relationship: |
|
| City: |
Bothell |
| State: |
WA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
43,565 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$2,925,054 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
43,565 |
|
|
| Total
Value |
$2,925,054 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
8
|
|
Stock
price went up :
|
0
|
5
|
| Stock
price went down : |
0
|
3
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
1.7
|
| Percentage
Gain/Loss : |
0.0%
|
 122.7%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Cardiac Science Corp |
CSCX |
VP, Public Access |
2006-12-01 |
115 |
2006-12-01 |
0 |
Premium* |
|
|
Axonics Modulation Technologies,... |
AXNX |
|
2024-01-31 |
43,450 |
2020-01-30 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| AXNX |
Axonics Modulation Techno... |
Chief Commercial Officer |
• – – |
2024-01-31 |
4 |
S |
$67.74 |
$1,125,432 |
D/D |
(16,615) |
43,450 |
0 |
% |
|
| AXNX |
Axonics Modulation Techno... |
Chief Commercial Officer |
• – – |
2024-01-31 |
4 |
OE |
$0.00 |
$0 |
D/D |
25,500 |
60,065 |
0 |
- |
|
| AXNX |
Axonics Modulation Techno... |
Chief Commercial Officer |
• – – |
2023-08-15 |
4 |
AS |
$62.34 |
$920,671 |
D/D |
(14,769) |
34,565 |
0 |
% |
|
| AXNX |
Axonics Modulation Techno... |
Chief Commercial Officer |
• – – |
2023-07-28 |
4 |
AS |
$62.01 |
$93,021 |
D/D |
(1,500) |
49,334 |
0 |
% |
|
| AXNX |
Axonics Modulation Techno... |
Chief Commercial Officer |
• – – |
2023-02-01 |
4 |
S |
$60.43 |
$225,750 |
D/D |
(3,705) |
50,834 |
0 |
% |
|
| AXNX |
Axonics Modulation Techno... |
Chief Commercial Officer |
• – – |
2023-01-31 |
4 |
A |
$0.00 |
$0 |
D/D |
7,500 |
44,273 |
0 |
- |
|
| AXNX |
Axonics Modulation Techno... |
Chief Commercial Officer |
• – – |
2023-01-31 |
4 |
OE |
$0.00 |
$0 |
D/D |
16,500 |
60,773 |
0 |
- |
|
| AXNX |
Axonics Modulation Techno... |
Chief Commercial Officer |
• – – |
2023-01-31 |
4 |
S |
$61.12 |
$381,235 |
D/D |
(6,234) |
54,539 |
0 |
% |
|
| AXNX |
Axonics Modulation Techno... |
Chief Commercial Officer |
• – – |
2023-01-13 |
4 |
S |
$65.90 |
$2,391,415 |
D/D |
(36,015) |
36,773 |
0 |
% |
|
| AXNX |
Axonics Modulation Techno... |
Chief Commercial Officer |
• – – |
2023-01-13 |
4 |
OE |
$1.42 |
$486,817 |
D/D |
36,015 |
72,788 |
0 |
- |
|
| AXNX |
Axonics Modulation Techno... |
Chief Commercial Officer |
• – – |
2022-02-03 |
4 |
S |
$48.21 |
$447,152 |
D/D |
(9,267) |
36,773 |
0 |
% |
|
| AXNX |
Axonics Modulation Techno... |
Chief Commercial Officer |
• – – |
2022-02-03 |
4 |
OE |
$0.00 |
$0 |
D/D |
24,130 |
46,040 |
0 |
- |
|
| AXNX |
Axonics Modulation Techno... |
Chief Commercial Officer |
• – – |
2022-01-31 |
4 |
A |
$0.00 |
$0 |
D/D |
16,285 |
21,910 |
0 |
- |
|
| AXNX |
Axonics Modulation Techno... |
Chief Commercial Officer |
• – – |
2021-04-19 |
4 |
AS |
$58.33 |
$3,179,406 |
D/D |
(54,296) |
5,625 |
0 |
% |
|
| AXNX |
Axonics Modulation Techno... |
Chief Commercial Officer |
• – – |
2021-04-19 |
4 |
OE |
$1.42 |
$467,593 |
D/D |
46,197 |
59,921 |
0 |
- |
|
| AXNX |
Axonics Modulation Techno... |
Chief Commercial Officer |
• – – |
2021-02-01 |
4 |
S |
$51.36 |
$96,819 |
D/D |
(1,883) |
13,724 |
0 |
% |
|
| AXNX |
Axonics Modulation Techno... |
Chief Commercial Officer |
• – – |
2021-02-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
5,334 |
15,607 |
0 |
- |
|
| AXNX |
Axonics Modulation Techno... |
Chief Commercial Officer |
• – – |
2021-01-31 |
4 |
A |
$0.00 |
$0 |
D/D |
5,625 |
10,273 |
0 |
- |
|
| AXNX |
Axonics Modulation Techno... |
Chief Commercial Officer |
• – – |
2021-01-26 |
4 |
OE |
$0.00 |
$0 |
D/D |
7,065 |
7,065 |
0 |
- |
|
| AXNX |
Axonics Modulation Techno... |
Chief Commercial Officer |
• – – |
2021-01-26 |
4 |
S |
$53.58 |
$129,495 |
D/D |
(2,417) |
4,648 |
0 |
% |
|
| AXNX |
Axonics Modulation Techno... |
Chief Commercial Officer |
• – – |
2020-09-02 |
4 |
S |
$39.84 |
$1,408,230 |
D/D |
(35,000) |
0 |
0 |
% |
|
| AXNX |
Axonics Modulation Techno... |
Chief Commercial Officer |
• – – |
2020-09-02 |
4 |
OE |
$1.42 |
$49,700 |
D/D |
35,000 |
35,000 |
0 |
- |
|
| AXNX |
Axonics Modulation Techno... |
Chief Commercial Officer |
• – – |
2020-08-31 |
4 |
S |
$42.31 |
$112,845 |
D/D |
(2,667) |
0 |
0 |
% |
|
| AXNX |
Axonics Modulation Techno... |
Chief Commercial Officer |
• – – |
2020-01-30 |
4 |
OE |
$0.00 |
$0 |
D/D |
2,667 |
2,667 |
0 |
- |
|
| CSCX |
Cardiac Science Corp |
VP, Public Access |
• – – |
2006-12-01 |
4 |
D |
$8.12 |
$487 |
D/D |
(60) |
115 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
